3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Motor Activity
9
Breast Neoplasms
6
Neoplasms
4
Colorectal Neoplasms
3
Multiple Myeloma
2
Insulin Resistance
2
Cardiotoxicity
2
Weight Loss
1
Warts
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Lymphoma
1
Limb-girdle muscular dystrophy, type 2C
1
Leukemia, Myeloid, Acute
1
Hematologic Neoplasms
1
Fatigue
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus
1
Cognitive Dysfunction
1
Carcinoma, Hepatocellular
1
Cachexia
1
Brenner Tumor
1
Bone Metastases
1
Body Weight
1
Interventions
Glutamine
3
Physical Therapy Modalities
2
Acupuncture Therapy
2
glutamic acid diethyl ester
1
Thioctic Acid
1
Sugars
1
Pain Management
1
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
1
Minocycline
1
Low-Level Light Therapy
1
Ketamine
1
Glutamic Acid
1
Exercise
1
Epoetin Alfa
1
Duloxetine Hydrochloride
1
Dietary Supplements
1
Biopsy
1
Analgesia
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Peripheral Nervous System Diseases
×
Exercise
×
Clear all
NCT03430674
2023-03-27
Exercise
Indiana University
Phase NA
Completed
10 enrolled
12 charts